Navigation Links
Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
Date:2/12/2008

Aldrich in research reagents, and, as we heard today, by Dow AgroSciences in plant agriculture to positively effect changes in plant genomes at a speed, efficiency, and specificity which heretofore was only considered a dream," said Edward Lanphier, Sangamo's president and CEO. "Dow AgroSciences has the expertise to implement our technology successfully into its precision trait development program."

The three-year agreement initiated October 2005 provides Dow AgroSciences with access to Sangamo's proprietary ZFP technology for the development of products in plants and plant cell cultures. During the initial three-year research term, Dow AgroSciences has the option to obtain a commercial license to sell products incorporating or derived from plant cells generated using Sangamo's ZFP technology, including agricultural crops, industrial products and plant-derived biopharmaceuticals.

Sangamo has also developed sequence-specific ZFNs for precision gene modification and targeted gene insertion. These technologies have the potential to play a major role in bringing new discoveries in genomics forward to the marketplace. The use of Sangamo's ZFP technology to enable the efficient and reproducible generation of combinations or stacks of multiple traits and the insertion of new traits could address increasing demand.

About Dow AgroSciences LLC

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $3.8 billion. Learn more at http://www.dowagro.com. <
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
2. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
3. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
4. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
5. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
6. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
7. Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
8. Sangamo BioSciences to Present at the 2007 BIO InvestorForum
9. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
10. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
11. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCa...calcompanyfocusedondevelopingandcommercializingnov...yDiTonno,PresidentandChiefExecutiveOfficer,issched...Conference,tobeheldDecember1-2,2009atTheNewYorkPal...henGhiglieri,ChiefFinancialOfficer,willbeavailable...
(Date:11/24/2009)..., The FBI recently approv...aboratories participating in or generating DNA rec... Madison, WI USA (PRWEB) -- The FB... HS System for use by laboratories participating ...A Index System (NDIS). NDIS currently contains mor...
(Date:11/24/2009)...,, DUBLIN,November24/PRNewswire-FirstCall/--...tybiopharmaceuticalcompany,today,announcedthatitha...glucerasealfa,thecompany,senzymereplacementtherapy....Thisisthethirdmarketing,applicationforvelaglucera...sintheUnitedStatesandCanada. , Basedonaglobal...
(Date:11/24/2009)...,, BOZEN,Italy,November24/PRNewswire/--Healt...njointventurewithagroupofselected,investors.Thisre...e,nameHealthRoboticsCanada,Inc.andwillmarket,insta...ncept,whichincludesthe,revolutionaryproductofferin...oboticsCanadaInc.willalsoprovideassistanceonan"asn...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...Y, N.J., Jan. 28 Ferring Pharmaceuticals Inc.,has...XXA(TM) (1% sodium,hyaluronate) will serve as the ...s Hockey Championships and the EUFLEXXA GeezerJock...pportunity for both our brand and for,senior athle...TM). "We,support all that the National Senior Game...
..., Jan. 28 Lentigen Corporation today announced,th...e officer., David Wetherell, Lentigen,s chairman,...at Tim has agreed to lead Lentigen, as we are abou... later this year for Glioblastoma,and GVHD. His pa... in,healthcare products will serve Lentigen well a...
... Calif., Jan. 28 GenVault Corporation today,annou...s its Vice President,of Sales and Marketing. Mr. O...owth and operation of GenVault,s domestic and inte...f the substantial momentum for sustainable,biosamp... than 17 years experience in biotechnology sales,a...
Other Biology Technology:Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award 2Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award 3Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award 4Lentigen Appoints Tim Ravenscroft as Chief Executive Officer 2Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing 2
(Date:11/24/2009)... been prescribed by traditional healers in Brazil ...omach pain to fever and flu. , Now for the first ...n able to scientifically prove the pain relieving ... Brazilian mint. , Testing this ancient South Ame...ciela Rocha was able to show that when prepared as...
(Date:11/24/2009)...remarkable class of ring-shaped protein motors has...erkeley National Laboratory (Berkeley Lab) using a... at the Advanced Light Source (ALS). These protein...replication, and are vital to the survival of all ...ch as the human papillomavirus, which has been lin...
(Date:11/24/2009)...2009) New research on bacterial communities throu...edictable temporal patterns, suggesting that scien...onitoring climate change in the polar regions. The... the National Academy of Sciences Early Edition, ... shifted synchronously over time, correlating with...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 1New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 5New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 6Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 2Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 3Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 4Cord Blood Registry Maintains Solid Growth in First Quarter 2009 48560 1Cord Blood Registry Maintains Solid Growth in First Quarter 2009 48560 2Cord Blood Registry Maintains Solid Growth in First Quarter 2009 48560 3
... in no small part, on something akin to the square...eplicate in monkey cells, so researchers use a mon...on of simian immunodeficiency virus -- to test pot...apies and vaccines that are effective on SIV don,t...ing a combination of genetic engineering and force...
... is spelled out in our DNA and activated through o... a variety of methods that our cells have evolved .... , Among other things, epigenetics is crucial to... from another, and thus is at the heart of the mys...type of epigenetic change that causes one copy of ...
...(TB) has been linked to HIV/AIDS in a study conduc...chool of Medicine. , Published in the October 26 i...ive-year collaboration between a Yale and South Af... and TB care and treatment. , TB is the most co...infection in sub-Saharan Africa. HIV greatly incre...
Other Biology News:HIV gets a makeover 2Inheritance outside DNA 2HIV/AIDS linked to extensively drug resistant TB 2
Agarose, Type C from Calbiochem
Assay Diluent from BD Biosciences Pharmingen
Chicken Anti-Human Quinolinate phosphoribosyltransferase Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
ICC Diluent Buffer from BD Biosciences Pharmingen
Biology Products: